Three cases of bone metastases in patients with gastrointestinal stromal tumors

Three cases of bone metastases in patients with gastrointestinal stromal tumors

Gastrointestinal stromal tumors (GISTs) are rare, but represent the most common mesenchymal neoplasms of the gastrointestinal tract. Tumor resection is the treatment of choice for localized disease. Tyrosine kinase inhibitors (imatinib, sunitinib) are the standard therapy for metastatic or unresecta...

Full description

Bibliographic Details
Main Authors:	Maurizio Zompatori, Giorgio Garzillo, Guido Biasco, Maristella Saponara, Cristian Lolli, Anna Mandrioli, Monica Di Battista, Alberto Bazzocchi, Margherita Nannini, Alessandra Maleddu, Laura Greco, Maria Caterina Pallotti, Maria Abbondanza Pantaleo, Valerio Di Scioscio
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-04-01
Series:	Rare Tumors
Subjects:	GISTs, CT scan, bone metastases, Imatinib
Online Access:	http://www.pagepress.org/journals/index.php/rt/article/view/2307

Similar Items

Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor
by: Cristian Lolli, et al.
Published: (2011-10-01)

Crossing-over to imatinib 800 mg in a patient with GIST, after progression with standard dosage: a case report
by: Giuseppe Naso, et al.
Published: (2015-10-01)

Gastrointestinal Stromal Tumor (GIST) from esophagus to anorectum – diagnosis, response evaluation and surveillance on computed tomography (CT) scan
by: Sushil N Panbude, et al.
Published: (2019-04-01)

Imatinib as adjuvant therapy for high risk GIST: a case report
by: Patrizia Lista, et al.
Published: (2015-10-01)

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
by: Seidel Christoph, et al.
Published: (2012-05-01)

Appropriate durations of adjuvant imatinib in patients with high-risk gastrointestinal stromal tumor (GIST) the better choice, for the year 2010
by: Lucia Tozzi
Published: (2015-10-01)

Imatinib dose optimisation following the disease progression in a patient with metastatic GIST
by: Mariangela Parodi, et al.
Published: (2015-10-01)

Sarcomas del estroma gastrointestinal tratados con Imatinib®: presentación de 2 casos Gastrointestinal stromal tumors treated with Imatinib®: report of 2 cases
by: Mayté Lima, et al.
Published: (2006-06-01)

Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report)
by: Fousséni Alassani, et al.
Published: (2019-11-01)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
by: Christos Vallilas, et al.
Published: (2021-01-01)

A Surprise Visitor at Cesarean Section: Gastrointestinal Stromal Tumor of the Uterus
by: Simon Raif Marcos, et al.
Published: (2020-01-01)

Management of a case of high-risk gastrointestinal stromal tumor in rectum by transanal minimal invasive surgery
by: Pramod Nepal, et al.
Published: (2018-08-01)

Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis
by: Gloria Ravegnini, et al.
Published: (2015-07-01)

Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report
by: Antonio De Leo, et al.
Published: (2018-03-01)

A ruptured gastrointestinal stromal tumour of the small intestine: a case report
by: Ivan Lolli, et al.
Published: (2015-10-01)

Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
by: Annalisa Astolfi, et al.
Published: (2020-04-01)

A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
by: Bauer, S., et al.
Published: (2022)

Current Management of Gastrointestinal Stromal Tumor
by: Gautam Shubhankar, et al.
Published: (2020-01-01)

Gastrointestinal stromal tumors: The 2015 asco News
by: P P Arkhiri
Published: (2015-06-01)

Chloroquine Combined with Imatinib Overcomes Imatinib Resistance in Gastrointestinal Stromal Tumors by Inhibiting Autophagy via the MAPK/ERK Pathway
by: Zheng S, et al.
Published: (2020-07-01)

Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategies
by: Li GZ, et al.
Published: (2019-07-01)

Polekowe zapalenie skóry wywołane imatynibem u pacjentki z nowotworem podścieliska przewodu pokarmowego – opis przypadku
by: Hanna Myśliwiec, et al.
Published: (2011-07-01)

Advances and Challenges on Management of Gastrointestinal Stromal Tumors
by: Lin Mei, et al.
Published: (2018-05-01)

Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour
by: Alexandre Bertucci, et al.
Published: (2019-08-01)

cKIT Mutations in GISTs and Other Malignancies in Thailand
by: Thongbliew Prempree, et al.
Published: (2006-03-01)

Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib
by: Guangrong Zhu, et al.
Published: (2020-02-01)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
by: Shang-Yu Wang, et al.
Published: (2019-03-01)

Possible modulation of concurrent Parkinson’s disease in the management of metastatic GIST: a review of two cases
by: T Watson-Fargie, et al.
Published: (2018-09-01)

Gastrointestinal stromal tumor of rectum- a case report
by: Madhuri S.Kate, et al.
Published: (2012-11-01)

The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor
by: Annalisa Astolfi, et al.
Published: (2020-05-01)

Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor
by: Marya Kozinova, et al.
Published: (2021-07-01)

Type and Gene Location of <i>KIT</i> Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon
by: Lorena Incorvaia, et al.
Published: (2021-02-01)

The management of metastatic GIST: current standard and investigational therapeutics
by: Ciara M. Kelly, et al.
Published: (2021-01-01)

Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal Tumors
by: Xu H, et al.
Published: (2021-01-01)

Adjuvant therapy with imatinib mesilate in a patient with intermediate risk GIST
by: Giuseppe Aprile
Published: (2015-10-01)

MORPHOLOGICAL AND IMMUNOCYTOCHEMICAL CHARACTERISTICS OF STROMAL GASTROINTESTINAL TUMORS
by: Ivan Ilić, et al.
Published: (2010-09-01)

A RARE GIANT EXTRA-GASTROINTESTINAL STROMAL TUMOR (GIST) IN A YOUNG MALE PATIENT
by: Miljan Zindović, et al.
Published: (2014-12-01)

Humeral metastasis as the only recurrence of a 5-year resected gastrointestinal stromal tumor: a case report
by: C. Braunstein, et al.
Published: (2021-08-01)

The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)
by: Alessandro Rizzo, et al.
Published: (2021-02-01)

Langzeitüberleben von Patienten mit gastrointestinalen Stromatumoren - Risikofaktoren und Prognose des Göttinger Kollektivs
by: Krüsmann, Onno
Published: (2019)